About this trial
This prospective, single-center observational study will evaluate whether blood levels of glial fibrillary acidic protein (GFAP), a protein associated with injury to supporting cells in the brain, are related to neurological complications after carotid endarterectomy. Adults aged 35 to 90 years undergoing elective isolated carotid endarterectomy will be enrolled. Serum GFAP will be measured before surgery and 24 hours after surgery. Investigators will record perioperative clinical information and postoperative neurological outcomes, including transient ischemic attack, stroke, delirium, and cognitive dysfunction. Approximately 90 participants are planned. The study will not assign any treatment or procedure.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Age 35 to 90 years
Scheduled to undergo elective isolated carotid endarterectomy
Willing and able to provide informed consent and the required blood samples
Disqualifiers
Acute coronary syndrome within the previous 3 months
Carotid endarterectomy planned in combination with another surgical procedure
Atrial fibrillation
Known inflammatory disease
Trial population
Adults with carotid artery disease who are scheduled for elective isolated carotid endarterectomy and are treated at the Cardiovascular Surgery Clinic of Bursa Yuksek Ihtisas Training and Research Hospital.
Trial design
Cohort
Prospective
Treatments tested in this trial
Serum GFAP Measurement
Diagnostic testSerum glial fibrillary acidic protein (GFAP) is measured before carotid endarterectomy and 24 hours after surgery. The measurements are collected for observational analysis and do not determine the participant's clinical care.
Treatment groups
Trial outcomes
Primary outcomes
Number of Participants With Postoperative Neurological Complications
Number of participants who experience at least one postoperative neurological complication after carotid endarterectomy: transient ischemic attack, stroke, delirium, or cognitive dysfunction. A participant with more than one event will be counted once in this composite outcome.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Filiz Ata
Lead sponsor
Bursa Yuksek Ihtisas Training and Research Hospital
Sponsor institution